Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
- Martin, M.
- Brase, J.C.
- Ruiz, A.
- Prat, A.
- Kronenwett, R.
- Calvo, L.
- Petry, C.
- Bernard, P.S.
- Ruiz-Borrego, M.
- Weber, K.E.
- Rodriguez, C.A.
- Alvarez, I.M.
- Segui, M.A.
- Perou, C.M.
- Casas, M.
- Carrasco, E.
- Caballero, R.
- Rodriguez-Lescure, A.
ISSN: 1573-7217, 0167-6806
Year of publication: 2016
Volume: 156
Issue: 1
Pages: 81-89
Type: Article